Gastrointestinal Drugs Market 2017 by Segment, Country, Region & Forecasts to 2020
ReportsWeb.com published “Gastrointestinal Drugs Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, July 31, 2017 ) Gastrointestinal drug market covers the medicines used for the treatment of colon cancer, colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol); antiemetics; adsorbents; anticholinergics; opiates; intestinal flora modifiers; emollient/surfactants; hyperosmotic; saline; and simulant/irritant.
For more information about this report at http://www.reportsweb.com/gastrointestinal-drugs-market-global-report-2017
The global gastrointestinal drugs market was estimated to be around $52 billion as of 2016. The gastrointestinal drugs market made up around 5% of the overall pharmaceuticals market in 2016. The gastrointestinal drugs market was the tenth largest market in the global pharmaceutical market in 2016.
Increasing R&D Activities
Growing R&D activities for the development of new drugs in the treatment of gastrointestinal diseases is an emerging trend in the market. Some of the major gastrointestinal pipeline products include Perjeta (Roche); Keytruda (Merck); TAS-118 (Taiho Pharmaceutical); NeuVax (Galena Biopharma); Ipatasertib (Genentech); Durvalumab (AstraZeneca); and Napabucasin (Boston Biomedical). Technological advancements in the treatment of gastrointestinal diseases will boost the market during the forecast period.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890202/sample
Table of Content
1. Gastrointestinal Drugs Market Characteristics
2. Gastrointestinal Drugs Market Size And Growth
3. Pestle Analysis
4. Gastrointestinal Drugs Market Customer Information
5. Gastrointestinal Drugs Market Segmentation
6. Gastrointestinal Drugs Market Regional And Country Analysis
7. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors
8. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries
9. Gastrointestinal Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Gastrointestinal Drugs Market
11. Western Europe Gastrointestinal Drugs Market
12. Eastern Europe Gastrointestinal Drugs Market
13. North America Gastrointestinal Drugs Market
14. South America Gastrointestinal Drugs Market
15. Middle East Gastrointestinal Drugs Market
16. Africa Gastrointestinal Drugs Market
17. Gastrointestinal Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Antacids, Antiulcerants
Vitamin And Minerals
Antiobesity, Antiemetics
Antinauseants, Antidiarrhoeals
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890202/buying
For more information about this report at http://www.reportsweb.com/gastrointestinal-drugs-market-global-report-2017
The global gastrointestinal drugs market was estimated to be around $52 billion as of 2016. The gastrointestinal drugs market made up around 5% of the overall pharmaceuticals market in 2016. The gastrointestinal drugs market was the tenth largest market in the global pharmaceutical market in 2016.
Increasing R&D Activities
Growing R&D activities for the development of new drugs in the treatment of gastrointestinal diseases is an emerging trend in the market. Some of the major gastrointestinal pipeline products include Perjeta (Roche); Keytruda (Merck); TAS-118 (Taiho Pharmaceutical); NeuVax (Galena Biopharma); Ipatasertib (Genentech); Durvalumab (AstraZeneca); and Napabucasin (Boston Biomedical). Technological advancements in the treatment of gastrointestinal diseases will boost the market during the forecast period.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890202/sample
Table of Content
1. Gastrointestinal Drugs Market Characteristics
2. Gastrointestinal Drugs Market Size And Growth
3. Pestle Analysis
4. Gastrointestinal Drugs Market Customer Information
5. Gastrointestinal Drugs Market Segmentation
6. Gastrointestinal Drugs Market Regional And Country Analysis
7. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors
8. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries
9. Gastrointestinal Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Gastrointestinal Drugs Market
11. Western Europe Gastrointestinal Drugs Market
12. Eastern Europe Gastrointestinal Drugs Market
13. North America Gastrointestinal Drugs Market
14. South America Gastrointestinal Drugs Market
15. Middle East Gastrointestinal Drugs Market
16. Africa Gastrointestinal Drugs Market
17. Gastrointestinal Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Antacids, Antiulcerants
Vitamin And Minerals
Antiobesity, Antiemetics
Antinauseants, Antidiarrhoeals
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890202/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results